Abbott recalls Similac, other formulas because of seals on bottles

Abbott is initiating a recall of certain lots of 2-ounce/59 milliliter bottles of Ready-to-Feed liquid products for infants and children, including the brands Similac Pro-Total Comfort, Similac 360 Total Care, Similac 360 Total Care Sensitive, Similac Special Care 24, Similac Stage 1, Similac NeoSure, Similac Water (Sterilized) and Pedialyte Electrolyte Solution. 

The products included in the recall were manufactured at the Columbus, Ohio, manufacturing facility.

These products are being recalled because some bottles in the recalled lots have bottle caps that may not have sealed completely, which could result in spoilage. If spoiled product is consumed, gastrointestinal symptoms such as diarrhea and vomiting may occur.

Abbott is continuing production of Similac 2-ounce/59 milliliter Ready-to-Feed liquid formula products for hospitals and healthcare providers’ offices on a different production line. Similac infant formula will continue to be produced in alternative product sizes and formats for delivery to retail locations, in addition to increased production throughout the global manufacturing network.

The products included in the recall were distributed primarily to hospitals and to some doctors’ offices, distributors and retailers in the U.S., including Puerto Rico; one lot of products was sent to Barbados, Bermuda, Colombia, the Dominican Republic, Haiti, Jamaica, St. Croix and St. Thomas; and two lots were sent to Canada, Curacao, Panama, and Trinidad and Tobago.

If a product is included in the recall, do not use the product. To identify if your product is included, please visit similacrecall.com to view a list of impacted lot numbers or use the lot number checker on the webpage.

For questions, please contact Abbott’s Consumer Relations hotlines below in the country where you received product:

  • U.S.: +1-800-986-8540
  • Puerto Rico: +1-787-622-5454
  • Barbados: 246-417-0777
  • Bermuda: 279-5568
  • Canada: 1-855-733-4201
  • Colombia: 1-800-518-9379
  • Curacao: 737-2222 Ext. 235, 205
  • Dominican Republic: +1-849-200-1564
  • Haiti: 868-687-0223
  • Jamaica: 876-927-7098
  • Panama: 800-0410
  • St. Croix: 1(340) 690-7222
  • St. Thomas: 1(340) 690-7222
  • Trinidad & Tobago: 868-687-0223

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
COVID Drops to Tenth Leading Cause of Death in the U.S. thumbnail

COVID Drops to Tenth Leading Cause of Death in the U.S.

Infectious Disease > COVID-19 — But other mortality trends reflect the ongoing influence of the pandemic by Rachael Robertson, Enterprise & Investigative Writer, MedPage Today, August 8, 2024 After years of being in the top five leading causes of death in the U.S., COVID-19 dropped to tenth in 2023, according to provisional data. While more
Read More
Researchers advocate new approach to breast cancer prevention thumbnail

Researchers advocate new approach to breast cancer prevention

Credit: Unsplash/CC0 Public Domain A commentary by Mayo Clinic Cancer Center researchers published in the Journal of Clinical Oncology Practice suggests that advances in breast cancer prevention research have resulted in new and innovative opportunities to modify breast cancer risk and potentially reduce breast cancer incidence and mortality. "It is prudent for health care providers…
Read More
Index Of News
Total
0
Share